PDCC Q4 2025 Earnings Slight EPS Miss Amid Credit Market Uncertainty GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain CCLDO Q1 2026 Earnings Preferred Stock EPS Misses Estimates Flat Market Response NVO Q1 2026 Earnings EPS Surges Past Estimates as Obesity Drug Sales Drive Margin Gains KNSA Q1 2026 Earnings EPS Surpasses Estimates by 315 Despite Stock Decline BT Brands Inc BTBD Edges Higher as Bullish Momentum Tests Key Resistance Esperion Therapeutics ESPR Holds Steady Amid Key Support and Resistance Levels Renatus Tactical Acquisition Corp I Unit RTACU Hovers Near Key Support Amid Quiet Trading EDAP TMS Holds Steady Near Support After Modest Gain MLM Q1 2026 Earnings Slight EPS Miss Amid Solid Aggregate Demand Western Midstream Partners Q1 2026 Earnings EPS Beats Estimates by 1391 Stock Rises ZDGE Q1 2026 Earnings EPS Miss Weighs on Stock PureTech Health PRTC Q4 2024 Earnings ClinicalStage Firm Reports EPS Miss Shares Flat as Market Digests Pipeline Progress Target Q1 2026 Earnings EPS of 171 Amid Mixed Consumer Environment LPLA Q1 2026 Earnings Slight EPS Beat Amid Market Volatility Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress